Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

LongueVue Capital Invests in Pinnacle Clinical Research

November 16, 2022

Healthcare Services

LongueVue Capital, a New Orleans-based private equity firm, completed a growth investment in Pinnacle Clinical Research, a San Antonio-based multi-location clinical trial site network specializing in complex therapeutic areas including hepatology (NAFLD/NASH). The capital from LVC is intended to support Pinnacle’s organic and inorganic growth, expand clinical trial capacity, and enhance operational capabilities across its Texas sites.

Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute

February 28, 2025

Healthcare Services

LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.

LongueVue Capital Invests in Summit Clinical Research

October 26, 2022

Healthcare Services

LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.

Pinnacle Clinical Research Acquires Jubilee Clinical Research

September 27, 2024

Healthcare Services

LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.

Pinnacle Clinical Research Adds Five Sites to Network (KMC, CRCNJ, Bellaire, Palmetto, DRI)

June 18, 2024

Healthcare Services

Pinnacle Clinical Research, a portfolio company of LongueVue Capital, has acquired or partnered with five clinical research sites — Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute — expanding Pinnacle’s network to 12 U.S. sites. The transactions broaden Pinnacle’s geographic footprint and add CNS/Alzheimer’s and metabolic disease capabilities, strengthening the platform’s ability to serve sponsors and underrepresented patient populations.

Velocity Clinical Research Acquires VitaLink Research and National Research Institute

September 22, 2021

Healthcare Services

Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.